Medplus Shares Slide 4.8% on Q1 Miss

  Published 9 months ago

Medplus Health fell 4.8% after Q1 miss; Nomura cut target, citing rising costs and slower revenue growth.

  • Nomura maintained “buy” but trimmed target to Rs 1,030, implying 12.1% upside from current levels.
  • Q1 EBITDA missed due to elevated employee expenses; FY26–27 estimates cut by 15–22%.
  • Despite the drop, stock is still up 5.2% YTD; median analyst target stands at Rs 1,087.5.

You might like these

Sagar Cements Q1 Profit Turns Positive

SKF India Shares Rise on Profit Margins, Capex Plans

United Spirits Q2 Profit Soars

Ajmera Realty Sales Drop, Collections Rise

SSWL July Turnover Rises, Profit Dips

IndiGo Shares Volatile After Q1 Miss

Sakar Healthcare Stock Surges on EU Approval

News that matters the most ⚡